Summary
The fasting level of plasma very low density lipoproteins (VLDL) was increased by 30 to 50% in 12 healthy male volunteers treated with daily oral doses of hydrochlorothiazide 100 mg, chlorthalidone 100 mg or furosemide 80 mg for 3 weeks in a cross-over trial. Hydrochlorothiazide and chlorthalidone, but not furosemide, caused a 10% increase in cholesterol in the low density lipoproteins (LDL), whereas triglycerides and phospholipids in this fraction remained unchanged. High density lipoproteins (HDL) were not affected by any of the diuretics. Free palmitic and oleic acid in plasma were also increased during the treatment, perhaps because of an accumulation of cyclic 3′5′-AMP due either to the inhibitory action of diuretics on phosphodiesterase, or to secondary activation of the sympathetic nervous systems. This would activate lipolysis in fat tissue, which in turn may induce VLDL synthesis in the liver. Each of the diuretics caused a similar rise of 20 to 30% in the mean plasma uric acid, the which could not be correlated with either triglycerides or cholesterol. Plasma sodium was increased by 2% only by furosemide, whereas potassium was decreased by 15 and 19% by hydrochlorothiazide and chlorthalidone, respectively, but not by furosemide. Mean plasma creatinine rose by 3.5% on treatment with furosemide, and by 6% with the other two diuretics. Mean body weight was reduced by 1,4 to 2,0% during treatment. No change in fasting blood sugar, plasma protein level or hematocrit was found.
Similar content being viewed by others
References
Ames RP, Hill P (1975a) Elevation of serum lipids induced by diuretic drugs in hypertension. J Clin Pharmacol 15: 552
Ames RP, Hill P (1975b) Effect of different antihypertensive regimens on serum lipid concentrations (Abstract) Kidney Int 8: 436
Ames RP, Hill P (1976) Elevation of serum lipid levels during diuretic therapy of hypertension. Am J Med 61: 748–757
Baumgartner G, Glück Z, Weidmann P, Peheim E, Flammer J (1978) Increased ratio between serum β- and α-lipoproteins during diuretic therapy (Abstract) Kidney Int. 13: 535
Berkowitz D (1964) Blood lipid and uric acid interrelationships. J Am Med Assoc 190: 856–858
Chrysant SG, Neller GK, Dillard B, Fröhlich E (1976) Effects of diuretics on lipid metabolism in patients with essential hypertension. Angiology 27: 707–710
Eggstein M, Kreutz FH (1966) Eine neue Bestimmung der Neutralfette im Blut (1. u. 2. Mitteilung). Klin Wochenschr 44: 262–273
Gillet MP, Besterman EM (1975) Plasmaconcentrations of Lysolecithin and other phospholipids in the healthy population and in men suffering from artherosclerotic diseases. Atherosclerosis 22: 111–124
Glück Z, Weidman P, Mordasani R, Peheim E, Bachmann G, Keusch G, Riesen W (1979) Einfluß einer Diureticatherapie auf die Serumlipoproteine: ein unerwünschter Effekt? Schweiz Med Wochenschr 109: 104–108
Grünert, A (1975) Die mikroanalytische, selective Bestimmung der unveresterten langkettigen Fettsäuren im Serum. Klin Chem Klin Biochem 13: 409–412
Hatch FT, Lees RS (1968) Practical methods for plasma lipoprotein analysis. Adv Lipid Res 6: 1–68
Helgeland A, Hjermann I, Holme I, Leren P (1978) Serum triglycerides and serum uric acid in untreated and thiazidetreated patients with mild hypertension. Am J Med 64: 34–38
Himms-Hagen J (1972) Effects of catecholamines on metabolism. In: Blaschko H, Muscholl E (eds) Catecholamines (Handbook of experimental pharmacology, Vol 33) Springer, Berlin Heidelberg New York, PP 363–462
Holzgreve H (1973) Diuretika. In: Kuemmerle HP, Goosens H (eds) Klinik u. Therapie der Nebenwirkungen. Thieme Stuttgart, S 707–723
Johnson B, Bye C, Labrooy J, Munro-Faure D, Slack J (1974) The relation of antihypertensive treatment to plasma lipids and other vascular risk factors in hypertensives. Clin Sci Mol Med 47: 9–10
Lindgren FT, Jensem LC, Hatch FT (1972) The isolation and quantitative analysis of serum lipoproteins. In: Nelson GJ (ed) Blood lipids and lipoproteins: Quantitation, composition and metabolism. Wiley — Interscience, New York, pp 181–274
Nelson GJ (1972) Handling, extraction and storage of blood samples. In: Nelson GJ (ed) Blood lipids and lipoproteins: Quantitation, composition and metabolism. Wiley — Interscience, New York, pp 3–24
Röschlau P, Bernt E, Gruber W (1974) Enzymatische Bestimmung des Gesamt-Cholesterins im Serum. Klin Chem Klin Biochem 12: 403–407
Senft G, Losert W, Schultz G, Sitt R, Bartelheimer HK (1966) Ursachen der Störungen im Kohlenhydratstoffwechsel unter dem Einfluß sulfonamidierter Diuretika. Naunyn-Schmiedeberg Arch Pharmacol Exp Pathol 255: 369–382
Schnaper H, Fitz A, Frohlich E, Goldman A, Perry jr. HM, Steele B (1977) Chlorthalidone and serum cholesterol. Lancet 2: 295
Schoenfeld MR, Goldberger E (1964) Hypercholesterolemia induced by thiazides: A pilot study. Curr Ther Res 6: 180–184
Sigurdsson G, Nicoll A, Lewis B (1975) Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects. J Clin Invest 56: 1481–1490
Talso PJ, Carballo AJ (1960) Effects of benzothiadiazines on serum and total body elelctrolytes. Ann Acad Sci 88: 822–840
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Joos, C., Kewitz, H. & Reinhold-Kourniati, D. Effects of diuretics on plasma lipoproteins in healthy men. Eur J Clin Pharmacol 17, 251–257 (1980). https://doi.org/10.1007/BF00625798
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00625798